Skip to main content
. 2019 Mar 25;24(11):e1091–e1101. doi: 10.1634/theoncologist.2018-0651

Figure 2.

image

Nomogram for predicting the 3‐ and 5‐year overall survival (OS) of patients with gastric cancer (GC) after surgery. (A): Nomogram for predicting the 3‐ and 5‐year OS of patients with GC after surgery. Calibration plot of the nomogram for (B) 3‐year and (C) 5‐year survival.

Abbreviation: SLMR, sarcopenia and the lymphocyte‐monocyte ratio.